Walid N. Hanna

Venture investor, PE Healthcare Advisor, Board Member, 25 years of Medtech experience
Professional background
  • Executive Chairman and Founder, Perseus Biomics (since 2019…): Ultra fast microbiome mapping technology platform
  • President and Founder of Medvent Group (since 2008—), managing a portfolio of 10 venture investments (Abionic, Mindmaze, HYT…)
  • President MindMaze Ventures (Gait Up, Intento, Curapy, Msquare…), Head Of Strategy / Corp Dev. MindMaze Group (since 2016—)
  • Former President Cardinal Health International Medical Products: revenues of 500M Usd, 800 employees (2002-2007)
  • Former Head Of BD at Medtronic Europe and different Finance leadership roles (1997-2003)
  • Ex Procter & Gamble (Brand Management), ex Paribas Affaires internationales (Project Finance/Merchant Banking)
Academic background
  • MBA Wharton , DESS Paris-Dauphine (212), Master of Law (Paris-Nanterre), IEP Dipl. Paris (Eco.Fin. )

Morten Beck

Morten Beck Jørgensen

Managing Director, Novo A/S

Msc in Finance and Accounting & Executive MBA from IMD

Professional background

Morten has his corporate background from Nordea in Copenhagen, Denmark where he worked in Investment Banking for 4 years. After the years in Nordea, Morten moved to Novo Nordisk A/S where he worked in Corporate Treasury for another 3 years.
Morten has for the last 10 years been responsible for building up an EUR 5 billion portfolio of financial assets in Novo A/S, the investment company of the Novo Nordisk Foundation

Academic background
  • Executive MBA at IMD, Switzerland

  • Msc. in Finance and Accounting from Aarhus University School of Business

  • Master program at San Francisco State University